| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2023―Nov―10 |
P-026 Dépistage et quantification des anticorps IgM et IgG Anti-Sars-Cov-2 chez les donneurs de sang durant la période de pandémie Covid-19 |
Oumar Atoumane Kane, Macoura Gadj, Youssoupha Sene, Harouna Ousmane Sow, Kadidiatou Kebe, Alioune Badara Senghor |
| 2 |
[GO] |
2023―Nov―10 |
CO6-6 Bilan de l’utilisation du plasma de patients convalescents de la Covid-19 |
Lucile Malard, Elodie Pouchol, Nesrine Benhamed, Caroline Bacquet, Karine Lacombe, Florence Ader, Pierre Gallian, Thibaut Bocquet, Pierre Tiberghien, Pascale Richard, Sophie Le Cam, Pascal Morel |
| 3 |
[GO] |
2023―Nov―10 |
P-032 Séroprévalence de SRAS-CoV-2 chez les donneurs de sang pendant la pandémie de la Covid-19 au Centre National de Transfusion Sanguine de Côte d’Ivoire (CNTSCI) |
Saydou Kabore, Yassongui Mamadou Sekongo, Aya Jeanne Armande Ake, Jean-Jacques Renaud Dechi, Sidoine Konan, Sery Romuald Dasse |
| 4 |
[GO] |
2023―Nov―10 |
P-190 Transfusion de plasma de patients convalescents chez les immunodéprimés atteints de COVID-19 virémique: une étude rétrospective multicentrique |
Marjolaine Destremau, Mathilde Beguet-Yachine, Victor Hemar, Hélène Chaussade, Xavier Lafarge, Pantxika Bellecave, Marie-Edith Lafon, Elodie Blanchard, Fabrice Bonnet, Nahéma Issa, Fabrice Camou |
| 5 |
[GO] |
2023―Nov―10 |
P-090 Besoins transfusionnels des patients hospitalisés pour COVID-19: Expérience Sud-Tunisienne |
Yosra Jaoua, Nour Louati, Nesrine Kallel, Yosra Mejdoub, Taicir Rekik, Chakib Marrakchi, Sami Kammoun, Mounir Ben Jmeaa, Jalel Gargouri, Ikram Ben Amor, Hela Menif |
| 6 |
[GO] |
2023―Nov―10 |
P-223 Détection visuelle des mutations du SARS-CoV-2 |
Julien Gomez-Martinez, Steven Henry, Edouard Tuaillon, Philippe Van De Perre, Chantal Fournier-Wirth, Vincent Foulongne, Jean-Charles Brès |
| 7 |
[GO] |
2023―Nov―10 |
P-061 Quantification des anticorps IgM et IgG anti SARS-COV-2 chez les étudiants de l’ Université Cheikh Anta Diop de Daka |
Harouna Ousmane Sow |
| 8 |
[GO] |
2022―Nov―08 |
L-66 Le plasma convalescent COVID-19 pour le traitement de la COVID-19 |
Pierre Tiberghien, Pascal Morel, Maxime Desmarets, Pascale Richard, Thibaut Bocquet, Eric Toussirot, Antoine Durrbach, Karine Lacombe |
| 9 |
[GO] |
2022―Nov―08 |
L-64 Maintien de l’autosuffisance quantitative et qualitative en produits sanguins pendant l’épidémie de COVID-19 : expérience de l’EFS entre 2020 et 2022 |
Catherine Humbrecht, Hervé Isola, Chrystelle Claudel, Patrick Lagarde, Xavier Tinard, Philippe Dupont, Christian Gachet, Daniel Kientz |
| 10 |
[GO] |
2022―Nov―08 |
L-62 Transfusion et patients COVID-19 au cours de la 1ère vague |
Xavier Delabranche, Paul-Michel Mertes |
| 11 |
[GO] |
2022―Nov―08 |
P-06 Gestion de stock de sang au CRTS de Sfax, Tunisie : Deux ans de pandémie SARS-CoV-2 |
Hela Menif, Taicir Rekik, Jalel Gargouri, Nour Louati, Ikram Ben Amor |
| 12 |
[GO] |
2022―Oct―13 |
Blood-Type-A Is A COVID-19 Infection And Hospitalization Risk In A Turkish Cohort |
Meryem Cetin, Sirin Cetin, Ayse Ulgen, Wentian Li |
| 13 |
[GO] |
2022―Sep―06 |
Estimate of anti-SARS-CoV-2 spike IgG antibodies prevalence among Iranian population based on blood donations: A serial cross-sectional study during the third wave of the pandemic |
Fahimeh Ranjbar Kermani, Peyman Eshghi, Ali Arab-Khazaeli, Mahtab Maghsudlu, Sedigheh Amini Kafi-Abad, Amir Teimourpour, Mahmoudreza Pourkarim |
| 14 |
[GO] |
2022―Sep―02 |
1220-2020: the 800th anniversary of medical university teaching in the context of a new pandemic - inaugural lecture of the SFVTT biennial congress in Montpellier |
Gérald Chanques |
| 15 |
[GO] |
2022―Sep―01 |
Vaccination and SARS-CoV-2 seroprevalence in blood donors: Correspondence |
Pathum Sookaromdee, Viroj Wiwanitkit |
| 16 |
[GO] |
2022―Aug―05 |
Impact of vaccination on SARS-CoV-2 seroprevalence rate in French blood donors: an assessment as of july 2021 |
Pierre Gallian, Ahmed Slimani, Lucile Malard, Pascal Morel, Xavier de Lamballerie |
| 17 |
[GO] |
2022―Jun―03 |
Positive direct antiglobulin tests in cancer patients hospitalized with COVID-19: a brief report from India |
Suvro Sankha Datta, Sabita Basu, Debapriya Basu, Mahua Reddy, Soumyadip Chatterji |
| 18 |
[GO] |
2022―May―02 |
COVID-19 : viral infection, endotheliopathy and the immuno-inflammatory response… is it time to consider a standard (non-immunized) plasma therapy approach to maintain homeostasis? |
Frederique Dufour-Gaume, Emilie Javelle, Anne Sailliol, Andre P. Cap, Nicolas J. Prat |
| 19 |
[GO] |
2022―Feb―12 |
SARS-CoV-2 Neutralizing Capacity among Blood Donors without prior COVID-19 symptomatic history vs Blood Donors with prior COVID-19 symptomatic history: A Comparative Study |
Ushasree Ravula, Srinivasa Rao Chunchu, Srujaleswari Mooli, Ravi Naik, Pandu Ranga Rao Sarangapati |
| 20 |
[GO] |
2021―Dec―29 |
Diminution significative des taux de transfusion pendant la pandémie de COVID-19 dans le nord-est de l’Iran |
Samaneh Boroumand-Noughabi, Atefe Rahmati, Negar Morovatdar, Mohammadreza Keramati |
| 21 |
[GO] |
2021―Dec―29 |
SARS-CoV-2 variants in immunocompromised COVID-19 patients: The underlying causes and the way forward |
Naveen Bansal, Manish Raturi, Yashik Bansal |
| 22 |
[GO] |
2021―Dec―16 |
Seroprevalence of SARS-CoV-2 among blood donors: A practical serosurveillance tool for COVID-19 |
Naveen Bansal, Manish Raturi, Yashik Bansal |
| 23 |
[GO] |
2021―Dec―11 |
COVID-19 Convalescent plasma use in the oncology and geriatric patients: Ethical aspects in transfusion medicine |
Naveen Bansal, Manish Raturi, Yashik Bansal |
| 24 |
[GO] |
2021―Nov―23 |
Organisation de la collecte, préparation, qualification et mise à disposition de plasmas issus de donneurs convalescents de la COVID-19 |
Thibaut Bocquet, Hervé Meinrad, Cathy Bliem, Pascal Morel |
| 25 |
[GO] |
2021―Nov―23 |
Le coombs direct, phénomène « transmissible » chez les patients COVID-19 |
Alice Brochier, Véronique Deneys |
| 26 |
[GO] |
2021―Nov―23 |
Suivi cartographique des prélèvements de produits sanguins et de l’épidémie de la COVID-19 |
Philippe-Antoine Halbout, Martin Lucas, Hervé Meinrad |
| 27 |
[GO] |
2021―Nov―23 |
Groupe sanguin ABO et COVID-19 |
Rania Hadj Taieb, Sonia Mahjoub, Nouha Ben Amara, Aya Chakroun, Héla Baccouche, Neila Ben Romdhane |
| 28 |
[GO] |
2021―Nov―23 |
L’impact de la pandémie COVID-19 sur la continuité des soins transfusionnels pour les patients thalassémiques : à propos d’un cas |
Sabah Bouhou, Mohammed Benajiba, Azlarab Masrar |
| 29 |
[GO] |
2021―Nov―23 |
Gestion de l’impact de la pandémie COVID-19 sur le système transfusionnel: expérience du Centre national marocain de transfusion sanguine et d’hématologie (CNTSH) |
Sabah Bouhou, Khadija Lahjouji, Mohammed Benajiba, Azlarab Masrar |
| 30 |
[GO] |
2021―Nov―23 |
Profils d’anticorps dans le plasma de convalescent COVID-19 traité pour traitement de réduction des agents pathogènes par Amotosalen/UVA |
Laurence Corash, Jean-Marc Payrat, Anil Bagri |
| 31 |
[GO] |
2021―Nov―23 |
PFC Covid-19, un an d’hémovigilance à Saint-Antoine AP-HP |
Virginie De La Taille, Sabine Guessant |
| 32 |
[GO] |
2021―Nov―23 |
Groupe sanguin ABO et sévérité de la COVID-19 : étude monocentrique |
Imene Dimassi, Sonia Mahjoub, Rahma Cherni, Héla Baccouche, Aya Chakroun, Neila Ben Romdhane |
| 33 |
[GO] |
2021―Nov―23 |
Délai de don de sang après vaccination COVID-19 : l’état actuel des recommandations |
Sabah Bouhou, Khadija Lahjouji, Azlarab Masrar |
| 34 |
[GO] |
2021―Nov―23 |
Plasma de convalescents du COVID-19 : premiers résultats en AURA |
Marion François, Michel Raba, Caroline Baud |
| 35 |
[GO] |
2021―Nov―23 |
Bilan des FIPDs COVID-19 déclarées sur e-FIT |
Sixtine Drougard, Karim Boudjedir, Imad Sandid, Muriel Fromage, Caroline Matko, Isabelle Sainte-Marie, Isabelle Yoldjian |
| 36 |
[GO] |
2021―Nov―23 |
Faisabilité de la transfusion de plasma de donneurs convalescents pour COVID-19 en réanimation |
Fabrice Camou, Mathilde Beguet-Yacine, Marie-Edith Lafon, Xavier Lafarge, Pantxika Bellecave, Fabrice Bonnet, Nahema Issa |
| 37 |
[GO] |
2021―Nov―23 |
Impact du COVID-19 et du confinement sur la transfusion |
Xavier Delabranche, Daniel Kientz, Charles Tacquard, Françoise Bertrand, Anne-Claude Roche, Pierre Tran Ba Loc, Catherine Humbrecht, Florian Sirlin, Xavier Pivot, Olivier Collange, François Levy, Walid Oulehri, Christian Gachet, Paul-Michel Mertes |
| 38 |
[GO] |
2021―Nov―23 |
Coombs direct positif chez les patients COVID-19 et transfusion : arbre décisionnel |
Julien Cabo |
| 39 |
[GO] |
2021―Nov―23 |
Auto-anticorps anti-interférons de type I et COVID-19 sévère |
Paul Bastard, Adrian Gervais, Tom Le Voyer, Jérémie Rosain, Quentin Philippot, Jean-Laurent Casanova, Qian Zhang, Emmanuelle Jouanguy, Pierre Tiberghien, Anne Puel |
| 40 |
[GO] |
2021―Nov―23 |
Protocole d’usage thérapeutique du plasma de convalescent de COVID-19-Suivi |
Anne-Marie Fillet, Virginie Ferrera-Tourenc, Marion François, Anne François, Valérie Porra, Isabelle Dettori, Eric Resch, Catherine Humbrecht, Géraldine Bourreille, Mathilde Beguet, Fanny Delettre, Françoise Hervé, France Pirenne, Michel Raba, Pascal Morel, Pascale Richard |
| 41 |
[GO] |
2021―Nov―23 |
AHAI révélant une infection par le coronavirus SARS-CoV-2 chez un nourrisson |
Manel Hsairi, Ameni Khemekhem, Taicir Rekik, Ghada Baccar, Hela Menif, Abdelamjid Mahfoudh, Ikram Ben Amor |
| 42 |
[GO] |
2021―Nov―23 |
Gestion du don de sang lors de la pandémie SARS-CoV-2 |
Taicr Rekik, Hela Menif, Ameni Khemekhem, Narjes Mezghani, Jalel Gargouri, Nour Louati, Ikram Ben Amor |
| 43 |
[GO] |
2021―Nov―23 |
Le risque de transmission du SARS-CoV-2 par le sang et les produits sanguins : l’état actuel des connaissances |
Sabah Bouhou, Mohammed Benajiba, Azlarab Masrar |
| 44 |
[GO] |
2021―Nov―23 |
Information post-don (IPD) SARS-CoV-2 avec transfusion de concentré de globules rouges (CGR) chez un receveur immunodéprimé |
Philippe Cabre, Emmanuelle Boulanger, Dorine Seuront-Scheffbuch |
| 45 |
[GO] |
2021―Nov―23 |
Quelle place pour les tests sérologiques SARS-CoV-2 chez la population des donneurs de sang ? |
Sabah Bouhou, Imane Douabi, Khadija Lahjouji, Mohammed Benajiba, Azlarab Masrar |
| 46 |
[GO] |
2021―Nov―23 |
DGVRetroDon : contribution à l’évaluation du risque de transmission du SARS-CoV-2 par transfusion par un dépistage de l’ARN viral plasmatique dans des dons de sang en France |
Sophie Le Cam, Céline Ricard, Céline Narboux, Valérie Barlet, Claude Maugard, Pierre Cappy, Dorothée Cannet, Josiane Pillonel, Pierre Gallian, Syria Laperche, Pascal Morel |
| 47 |
[GO] |
2021―Nov―23 |
Place de l’hémovigilance dans le contexte de la pandémie Sars-Cov2 |
Ilham Lemssahli, Khadija Lahjouji, Sabah Bouhou |
| 48 |
[GO] |
2021―Oct―13 |
SARS COV-2- IgG antibodies in blood donors in pandemic - a game changer for policy makers |
Smita Mahapatra |
| 49 |
[GO] |
2021―Aug―28 |
Failure of plasma therapy in Covid-19 |
Pathum Sookaromdee, Viroj Wiwanitkit |
| 50 |
[GO] |
2021―Aug―16 |
Efficient inactivation of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in human apheresis platelet concentrates with amotosalen and ultraviolet A light |
Salwa I Hindawi, Sherif A El-Kafrawy, Ahmed M Hassan, Maha A. Badawi, Maiman M. Bayoumi, Ahmad A. Almalki, Hosam M. Zowawi, Ahmed M Tolah, Thamir A Alandijany, Qossay Abunada, Marcus Picard-Maureau, Ghazi A Damanhouri, Esam I Azhar |
| 51 |
[GO] |
2021―Aug―12 |
Has plasma therapy failed in Covid-19 or we have failed in using it properly in India? -lessons learned through the pandemic |
Suvro Sankha Datta, Ritam Chakrabarty |
| 52 |
[GO] |
2021―Aug―03 |
Convalescent Covid-19 plasma: Back-to-basics and ethics, and next steps |
O. Garraud, T. Burnouf |
| 53 |
[GO] |
2021―Jul―29 |
Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma |
Massimo Franchini, Fausto Baldanti, Elena Percivalle, Alessandro Ferrari, Pietro Biasi, Giancarlo Maria Liumbruno, Claudia Glingani |
| 54 |
[GO] |
2021―Jul―22 |
Seroprevalence of SARS-CoV-2 among potential convalescent plasma donors and analysis of their deferral pattern: Experience from tertiary care hospital in western India |
Romesh Jain, M.V. Mallya, Sangeeta Amoncar, Sachin Palyekar, Harshad Popat Adsul, Rakesh Kumar, Sumit Chawla |
| 55 |
[GO] |
2021―Jul―01 |
SARS-CoV-2 infection in patients with β-thalassemia: the French experience |
Estelle Jean-Mignard, Gonzalo De Luna, Laurent Pascal, Imane Agouti, Isabelle Thuret |
| 56 |
[GO] |
2021―Jun―24 |
A novel scoring system for selecting the target patients of COVID-19 convalescent plasma therapy: A hypothesis |
Naveen Bansal, Manish Raturi, Yashik Bansal, Pushpendra Singh |
| 57 |
[GO] |
2021―Jun―15 |
COVID-19 convalescent plasma therapy for immunodeficient patients - weighing up risks and benefits |
Tomislav Vuk, Ana Hećimović, Irena Jukić, Sanda Ravlić, Tihana Kurtović, Dina Rnjak, Beata Halassy |
| 58 |
[GO] |
2021―Jun―15 |
La pénurie d'approvisionnement en sang induite par le Covid-19: Perspective d'un dépôt de sang tunisien |
Emna Hammami, Mariem Hadhri, Sarra Fekih Salem, Fatma Ben Lakhal, Wijden El Borgi, Emna Gouider |
| 59 |
[GO] |
2021―Jun―07 |
Positive Direct Antiglobulin Test in COVID-19 patients: decision-making process |
Julien Cabo, Alice Brochier, Pascale Saussoy, Marie-Astrid van Dievoet, Lena Capirchio, Bénédicte Delire, Véronique Deneys |
| 60 |
[GO] |
2021―Jun―05 |
Covid-19 convalescent plasma therapy: Analyzing factors that led to its failure in India |
Naveen Bansal, Manish Raturi, Yashik Bansal |
| 61 |
[GO] |
2021―May―29 |
Covid-19 convalescent plasma and SARS-CoV-2 viral variants |
Beuy Joob, Viroj Wiwanitkit |
| 62 |
[GO] |
2021―May―29 |
COVID-19 convalescent plasma therapy and immunodeficiency |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 63 |
[GO] |
2021―May―29 |
Blood Donation during COVID-19 Vaccination drive - The Need for Concern |
Tarun Kumar Suvvari, LV Simhachalam Kutikuppala, Naga Alekhya Garikipati, Sai Venkata Kalyani Ponnaganti, Venkata Ramana Kandi |
| 64 |
[GO] |
2021―May―19 |
Convalescent Plasma Therapy in the management of COVID-19 patients-The newer dimensions |
S. Mahapatra, R. Rattan, C.B.K. Mohanty |
| 65 |
[GO] |
2021―May―07 |
Locally harvested Covid-19 convalescent plasma could probably help combat the geographically determined SARS-CoV-2 viral variants |
Manish Raturi, Anuradha Kusum, Mansi Kala, Garima Mittal, Anita Sharma, Naveen Bansal |
| 66 |
[GO] |
2021―May―07 |
COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors |
Naveen Bansal, Manish Raturi, Yashik Bansal |
| 67 |
[GO] |
2021―Apr―24 |
COVID-19 convalescent plasma as long-term therapy in immunodeficient patients? |
D. Rnjak, S. Ravlić, A.-M. Šola, B. Halassy, J. Šemnički, M. Šuperba, A. Hećimović, I.-C. Kurolt, T. Kurtović, Ž. Mačak Šafranko, D. Polančec, K. Bendelja, T. Mušlin, I. Jukić, T. Vuk, L. Zenić, M. Artuković |
| 68 |
[GO] |
2021―Apr―22 |
Psychological assessment and lived experiences of recovered COVID-19 patients who presented for convalescent plasma donation |
A. Maheshwari, M. Varshney, K. Gupta, M. Bajpai |
| 69 |
[GO] |
2021―Apr―20 |
Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma |
Massimo Franchini, Claudia Glingani, Angela Bellani, Nicola Cicorella, Alessandro Amadini, Giuseppe De Donno, Salvatore Casari |
| 70 |
[GO] |
2021―Apr―19 |
What has changed after the COVID-19 pandemic in the publication process? A look-back to “Transfusion clinique et biologique” |
O. Garraud |
| 71 |
[GO] |
2021―Apr―13 |
Vaccination COVID-19 chez les donneurs de sang indiens: évaluer l'impact sur la période de report |
Naveen Bansal, Manish Raturi |
| 72 |
[GO] |
2021―Apr―08 |
Bioethical Perspective of Convalescent Plasma Therapy for COVID-19: A Systematic Review |
Muhammad Ardi Munir, Pascal Adventra Tandiabang, Tri Setyawati, Amirah Basry, Asep Dwitama Cyio, Nurulhuda Rahman |
| 73 |
[GO] |
2021―Apr―08 |
What convalescent plasma in treating severe acute respiratory infections of viral aetiology can hint for COVID-19? Evidence from a meta-analysis |
Jun Zeng, Saifu Yin, Xinmiao Du, Turun Song, Tao Lin |
| 74 |
[GO] |
2021―Mar―06 |
Constraints And Challenges In Convalescent Plasma Collection Amidst The Covid 19 Pandemic- Strategies And Recommendations To Overcome These |
Smita Mahapatra, Sanghamitra Pati |
| 75 |
[GO] |
2021―Jan―14 |
Indian blood donor selection guidelines: Review in the context of the ongoing COVID-19 pandemic |
Kunal Das, Manish Raturi, Nitika Agrawal, Mansi Kala, Anuradha Kusum |
| 76 |
[GO] |
2020―Dec―05 |
Emergence of Ancient Convalescent plasma (CP) Therapy: to Manage COVID-19 Pandemic |
Barsha Dassarma, Satyajit Tripathy, Motlalepula Matsabisa |
| 77 |
[GO] |
2020―Dec―02 |
Unexpected increase of the compliance rate of transfusion requisition form after the COVID-19 outbreak |
Liyan Yang, Jing Feng, Yongmei Jiang |
| 78 |
[GO] |
2020―Dec―01 |
The impact of COVID-19 pandemic on blood supplies and transfusion services in Eastern Mediterranean Region |
Arwa Z Al Riyami, Yetmgeta E Abdella, Maha A Badawi, Sathiya M Panchatcharam, Yasser Ghaleb, Mahtab Maghsudlu, Maria Satti, Khadija Lahjouji, Zayd Merenkov, Asia Adwan, Rita Feghali, Naji Gebril, Suha Hejress, Slama Hmida, Hind AlHumaidan, Durenaz Jamal, Osama Najjar, May Raouf |
| 79 |
[GO] |
2020―Nov―06 |
COVID-19, transfusion, and publishing ethics |
O. Garraud |
| 80 |
[GO] |
2020―Oct―20 |
Post-donation information and haemovigilance reporting for COVID-19 in Greece: information supporting the absence of SARS-CoV-2 possible transmission through blood components |
Constantina Politis, Maria Papadaki, Lida Politi, Georgia Kourti, Clive Richardson, Marina Asariotou, Athanassios Tsakris, Andreas Mentis |
| 81 |
[GO] |
2020―Oct―19 |
The Impact of COVID-19 on Transfusion-Dependent Thalassemia Patients of Karachi, Pakistan: A Single-Center Experience |
Shajeea Arshad Ali, Dua Azim, Hafiz Muhammad Hassan, Ayman Iqbal, Naseem Ahmed, Sohail Kumar, Sundus Nasim |
| 82 |
[GO] |
2020―Oct―17 |
Assessment of blood supply and usage pre- and during COVID-19 pandemic; a lesson from non-voluntary donation |
Christopher Ogar Ogar, Henshaw Uchechi Okoroiwu, Emmanuel Ifeanyi Obeagu, Joyce Ezekiel Etura, Dennis Akongfe Animye |
| 83 |
[GO] |
2020―Oct―03 |
Prevention and treatment of COVID-19-associated hypercoagulability: recommendations of the Algerian society of transfusion and hemobiology |
Chekkal Mohamed, Deba Tahra, Hadjali Soraya, Lamara Hassiba, Oulaa Hanifa, Zouai Karima, Hariti Ghania |
| 84 |
[GO] |
2020―Sep―25 |
A case of COVID-19 Convalescent Plasma Donation in Greece: directed donation for compassionate use in the donor's critically ill father |
Glykeria Vlachogianni, Helen Hassapopoulou-Matamis, Constantina Politis, Eirini Fylaki, Andreas Mentis |
| 85 |
[GO] |
2020―Sep―25 |
ABO blood group system is associated with COVID-19 mortality: An epidemiological investigation in the Indian population |
Sunali Padhi, Subham Suvankar, Debabrata Dash, Venketesh K. Panda, Abhijit Pati, Jogeswar Panigrahi, Aditya K Panda |
| 86 |
[GO] |
2020―Jul―10 |
Because Every Drop Counts: Blood Donation During the COVID-19 Pandemic |
Kamal Kant Sahu, Manish Raturi, Ahmad Daniyal Siddiqui, Jan Cerny |
| 87 |
[GO] |
2020―Jun―12 |
Plasma from donors convalescent from SARS-CoV-2 infection - A matter of priorities |
Albert Farrugia |
| 88 |
[GO] |
2020―May―16 |
Use of convalescent plasma in COVID-19 patients in China |
Mei Zhu, Hu Kaiming, Zhijun Zhu |
| 89 |
[GO] |
2020―May―07 |
A quick “Can I donate blood” self-assessment tool amid the COVID-19 outbreak |
M. Raturi |
| 90 |
[GO] |
2020―Apr―27 |
The Blood Supply Management amid the COVID-19 Outbreak |
Manish Raturi, Anuradha Kusum |
| 91 |
[GO] |
2020―Mar―31 |
The Active Role of a Blood Center in Outpacing the Transfusion Transmission of COVID-19 |
Manish Raturi |
| 92 |
[GO] |
2020―Mar―31 |
COVID-19: Is a paradigm change to be expected in health care and transfusion medicine? |
Olivier Garraud |
